1 January – 30 June (unaudited)
|
kEUR |
H1 2026 |
H1 2025 |
|
|
|
|
|
|
|
Result for the period |
|
9,081 |
-26,539 |
|
|
|
|
|
|
Other comprehensive income to be reclassified to profit or loss in subsequent periods |
|
|
|
|
Exchange differences on translation of foreign operations, net of tax |
|
-568 |
-2,437 |
|
Net other comprehensive income to be reclassified to profit or loss in subsequent periods |
|
-568 |
-2,437 |
|
|
|
|
|
|
Other comprehensive income not to be reclassified to profit or loss in subsequent periods |
|
|
|
|
Remeasurement gain / (loss) on defined benefit plans |
|
143 |
2,866 |
|
Income tax effect |
|
-44 |
-626 |
|
Net other comprehensive income not to be reclassified to profit or loss in subsequent periods |
|
99 |
2,240 |
|
Other comprehensive result for the period, net of taxes |
|
-469 |
-197 |
|
|
|
|
|
|
Total comprehensive result for period, net of taxes |
|
8,612 |
-26,736 |
|
|
|
|
|
|
Attributable to shareholders of PolyPeptide Group AG |
|
8,612 |
-26,736 |